UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database

Study Type – Therapy (outcomes) Level of Evidence 2b What’s known on the subject? and What does the study add? A slowly emerging body of urological outcome data reports lends increasing credence to the intuitive hypothesis that high volume surgeons have better surgical outcomes. This large scale pro...

Full description

Saved in:
Bibliographic Details
Published inBJU international Vol. 109; no. 3; pp. 346 - 354
Main Authors Vesey, Sean G., McCabe, John E., Hounsome, Luke, Fowler, Sarah
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.02.2012
Wiley-Blackwell
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1464-4096
1464-410X
1464-410X
DOI10.1111/j.1464-410X.2011.10334.x

Cover

Abstract Study Type – Therapy (outcomes) Level of Evidence 2b What’s known on the subject? and What does the study add? A slowly emerging body of urological outcome data reports lends increasing credence to the intuitive hypothesis that high volume surgeons have better surgical outcomes. This large scale prospective British Radical Prostatectomy study adds weight to this increasing body of evidence by supporting the hypothesis and also in raising the suggestion that current UK guidelines with respect to minimum surgeon case volume be significantly increased. OBJECTIVE • To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon. MATERIALS AND METHODS • All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. • Patient age, prostate‐specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. • The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence. RESULTS • A total of 8032 RP cases were entered on the database and Follow‐up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL. • Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. • The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre‐operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P  <  0.01). • When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8–10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. • Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum. CONCLUSIONS • High volume surgeons have less peri‐operative and postoperative complications and better surgical and disease‐free outcomes than low volume surgeons. • In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes.
AbstractList To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon. All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. Patient age, prostate-specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence. A total of 8032 RP cases were entered on the database and Follow-up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL. Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre-operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P < 0.01). When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8-10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum. High volume surgeons have less peri-operative and postoperative complications and better surgical and disease-free outcomes than low volume surgeons. In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes.
Study Type – Therapy (outcomes) Level of Evidence 2b What’s known on the subject? and What does the study add? A slowly emerging body of urological outcome data reports lends increasing credence to the intuitive hypothesis that high volume surgeons have better surgical outcomes. This large scale prospective British Radical Prostatectomy study adds weight to this increasing body of evidence by supporting the hypothesis and also in raising the suggestion that current UK guidelines with respect to minimum surgeon case volume be significantly increased. OBJECTIVE • To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon. MATERIALS AND METHODS • All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. • Patient age, prostate‐specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. • The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence. RESULTS • A total of 8032 RP cases were entered on the database and Follow‐up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL. • Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. • The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre‐operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P  <  0.01). • When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8–10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. • Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum. CONCLUSIONS • High volume surgeons have less peri‐operative and postoperative complications and better surgical and disease‐free outcomes than low volume surgeons. • In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes.
To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon.OBJECTIVETo undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon.All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. Patient age, prostate-specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence.MATERIALS AND METHODSAll RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. Patient age, prostate-specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence.A total of 8032 RP cases were entered on the database and Follow-up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL. Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre-operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P < 0.01). When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8-10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum.RESULTSA total of 8032 RP cases were entered on the database and Follow-up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL. Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre-operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P < 0.01). When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8-10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum.High volume surgeons have less peri-operative and postoperative complications and better surgical and disease-free outcomes than low volume surgeons. In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes.CONCLUSIONSHigh volume surgeons have less peri-operative and postoperative complications and better surgical and disease-free outcomes than low volume surgeons. In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes.
Study Type - Therapy (outcomes) Level of Evidence2b What's known on the subject? and What does the study add? A slowly emerging body of urological outcome data reports lends increasing credence to the intuitive hypothesis that high volume surgeons have better surgical outcomes. This large scale prospective British Radical Prostatectomy study adds weight to this increasing body of evidence by supporting the hypothesis and also in raising the suggestion that current UK guidelines with respect to minimum surgeon case volume be significantly increased. OBJECTIVE *To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon. MATERIALS AND METHODS *All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. *Patient age, prostate-specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. *The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence. RESULTS *A total of 8032 RP cases were entered on the database and Follow-up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3ng/mL. *Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. *The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre-operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P< 0.01). *When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8-10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. *Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum. CONCLUSIONS *High volume surgeons have less peri-operative and postoperative complications and better surgical and disease-free outcomes than low volume surgeons. *In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes. [PUBLICATION ABSTRACT]
Author Hounsome, Luke
McCabe, John E.
Fowler, Sarah
Vesey, Sean G.
Author_xml – sequence: 1
  givenname: Sean G.
  surname: Vesey
  fullname: Vesey, Sean G.
– sequence: 2
  givenname: John E.
  surname: McCabe
  fullname: McCabe, John E.
– sequence: 3
  givenname: Luke
  surname: Hounsome
  fullname: Hounsome, Luke
– sequence: 4
  givenname: Sarah
  surname: Fowler
  fullname: Fowler, Sarah
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25461866$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21771246$$D View this record in MEDLINE/PubMed
BookMark eNqVkttuEzEQhleoiB7gFZAlhLjK4rHXe-ACqQ1nKvWCRuLOmjhO62h3HTxeSB6Gd8WbpEXqFViWPB5_MyP_M6fZUe97m2UMeA5pvV7lUJTFpAD-PRccIAcuZZFvHmUn9w9HdzZvyuPslGjFeXKU6kl2LKCqQBTlSfZ79pUFXDiDLVsHTxGjNdF3W-aHaHxniWG_YDSEG-t7ZpAs--nbobNv2DxdFix5cdzYbskR80sWby27CC46umXnRN44jC5h6WkWfOtvdtW-7VMSm_pu3doNu1rbsAOJvcOIY_an2eMltmSfHc6z7PrD--vpp8nl1cfP0_PLiSlEVUwWBrEysrTAoURlBCgFVSlqqKuqEWKpQEqJjeBzgUmBQqIFUDUKEPN5I8-yV_u0SYEfg6WoO0fGti321g-kGygV1KouEvniAbnyQ0h_Jw1SSalEU_NEPT9Qw7yzC70OrsOw1XeyJ-DlAUBKWiwD9sbRX04VJdTlyNV7zqTWULDLewS4HidBr_TYZD02XI-ToHeToDcp9O2DUOPiTt4Y0LX_keCXa-32nwvriy-znSn_AODTzRk
CODEN BJINFO
CitedBy_id crossref_primary_10_1111_bju_12866
crossref_primary_10_1111_bju_15516
crossref_primary_10_1186_s12894_019_0526_9
crossref_primary_10_1111_bju_15656
crossref_primary_10_1111_bju_14687
crossref_primary_10_1007_s00345_015_1540_5
crossref_primary_10_1111_bju_14541
crossref_primary_10_1097_SLA_0000000000000852
crossref_primary_10_1186_1471_2490_14_82
crossref_primary_10_1016_j_eururo_2013_04_012
crossref_primary_10_1002_nau_24143
crossref_primary_10_1186_1471_2490_14_86
crossref_primary_10_2217_fon_13_3
crossref_primary_10_1016_j_juro_2011_12_080
crossref_primary_10_1016_j_eururo_2021_04_028
crossref_primary_10_1007_s00120_020_01321_7
crossref_primary_10_1177_1756287212447092
crossref_primary_10_1038_bjc_2013_589
crossref_primary_10_1016_j_urolonc_2016_09_003
crossref_primary_10_1016_j_euf_2017_03_008
crossref_primary_10_1016_j_eururo_2013_11_018
crossref_primary_10_1007_s13629_013_0003_2
crossref_primary_10_1177_2051415816664272
crossref_primary_10_1016_j_fertnstert_2018_03_020
crossref_primary_10_3109_00365599_2012_707684
crossref_primary_10_1016_j_urology_2015_11_026
crossref_primary_10_1016_j_urolonc_2019_01_006
crossref_primary_10_1097_MOP_0000000000000214
crossref_primary_10_5301_uro_5000125
crossref_primary_10_1111_j_1464_410X_2012_11367_x
crossref_primary_10_1007_s11701_022_01517_3
crossref_primary_10_1016_j_clon_2016_02_004
crossref_primary_10_1016_j_urolonc_2017_02_007
crossref_primary_10_1186_s13014_022_02046_x
crossref_primary_10_1177_20514158211063964
Cites_doi 10.1016/j.eururo.2006.02.051
10.1111/j.1464-410X.2007.07118.x
10.1016/j.eururo.2009.01.036
10.1111/j.1464-410X.2005.05717.x
10.1016/j.urolonc.2005.11.039
10.1136/bmj.c1128
10.1016/j.juro.2008.01.107
10.1016/S0022-5347(05)65177-4
10.1016/j.juro.2006.04.048
10.1016/S0022-5347(05)64670-8
10.1056/NEJMsa035205
10.1016/j.juro.2010.08.003
10.1097/01.ju.0000169475.00949.78
10.1016/j.urolonc.2009.07.014
10.1016/j.urolonc.2009.03.001
10.1111/j.1464-410X.2005.05245.x
10.1016/j.eururo.2008.12.001
10.1046/j.1464-410X.1996.00619.x
10.3109/00365590902916930
10.1111/j.1464-410X.2008.08169.x
ContentType Journal Article
Copyright 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL
2015 INIST-CNRS
2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
Copyright_xml – notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL
– notice: 2015 INIST-CNRS
– notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7X8
DOI 10.1111/j.1464-410X.2011.10334.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Calcium & Calcified Tissue Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1464-410X
EndPage 354
ExternalDocumentID 2975470011
21771246
25461866
10_1111_j_1464_410X_2011_10334_x
BJU10334
Genre article
Journal Article
GeographicLocations United Kingdom
Europe
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7X8
ID FETCH-LOGICAL-c4274-dcaa7c36e1016a5c2155176281877922f51333a920b2a66543ae1158a212bb93
IEDL.DBID DR2
ISSN 1464-4096
1464-410X
IngestDate Thu Oct 02 21:05:24 EDT 2025
Tue Oct 07 06:23:47 EDT 2025
Wed Feb 19 01:58:00 EST 2025
Mon Jul 21 09:14:16 EDT 2025
Thu Apr 24 23:07:20 EDT 2025
Wed Oct 01 04:28:49 EDT 2025
Wed Jan 22 16:48:15 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Nephrology
Prognosis
Prostate disease
Size
Operation
Urinary tract
Urology
prostate size
Association
radical prostatectomy
Surgery
Database
Urogenital system
Male genital diseases
outcome
Urinary system disease
Malignant tumor
Complexes
Surgeon
surgeon volume
Treatment
Urinary system
Volume
Prostatectomy
Prostate cancer
Prostate
Cancer
Language English
License CC BY 4.0
2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4274-dcaa7c36e1016a5c2155176281877922f51333a920b2a66543ae1158a212bb93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 21771246
PQID 1353352980
PQPubID 1026371
PageCount 9
ParticipantIDs proquest_miscellaneous_916518584
proquest_journals_1353352980
pubmed_primary_21771246
pascalfrancis_primary_25461866
crossref_primary_10_1111_j_1464_410X_2011_10334_x
crossref_citationtrail_10_1111_j_1464_410X_2011_10334_x
wiley_primary_10_1111_j_1464_410X_2011_10334_x_BJU10334
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2012
PublicationDateYYYYMMDD 2012-02-01
PublicationDate_xml – month: 02
  year: 2012
  text: February 2012
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
– name: Edgecliff
PublicationTitle BJU international
PublicationTitleAlternate BJU Int
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Wiley-Blackwell
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley-Blackwell
– name: Wiley Subscription Services, Inc
References 2009; 56
2009; 55
2003; 349
2005; 174
2006; 50
2009; 43
2006; 24
2010; 28
2002; 168
2007; 100
2002; 167
2005; 95
2005; 96
2006; 176
2010; 340
2010; 184
2008; 179
2009; 103
1996; 78
e_1_2_8_23_2
e_1_2_8_24_2
e_1_2_8_25_2
e_1_2_8_26_2
e_1_2_8_9_2
e_1_2_8_2_2
e_1_2_8_4_2
e_1_2_8_3_2
e_1_2_8_6_2
e_1_2_8_5_2
e_1_2_8_8_2
e_1_2_8_7_2
e_1_2_8_20_2
e_1_2_8_21_2
e_1_2_8_22_2
e_1_2_8_16_2
e_1_2_8_17_2
e_1_2_8_18_2
e_1_2_8_19_2
e_1_2_8_12_2
e_1_2_8_13_2
e_1_2_8_14_2
e_1_2_8_15_2
e_1_2_8_10_2
e_1_2_8_11_2
References_xml – volume: 168
  start-page: 514
  year: 2002
  end-page: 8
  article-title: Is a limited lymph node dissection an adequate staging procedure for prostate cancer?
  publication-title: J Urol
– volume: 176
  start-page: 991
  year: 2006
  end-page: 5
  article-title: Poorly differentiated prostate cancer treated with radical prostatectomy: long‐term outcome and incidence of pathological downgrading
  publication-title: J Urol
– volume: 28
  start-page: 219
  year: 2010
  end-page: 25
  article-title: Radical prostatectomy: does surgical technique influence margin control?
  publication-title: Urol Oncol
– volume: 95
  start-page: 34
  year: 2005
  end-page: 9
  article-title: Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time
  publication-title: BJU Int
– volume: 24
  start-page: 465
  year: 2006
  end-page: 71
  article-title: Survival results in patients with screen‐detected prostate cancer versus physician‐referred patients treated with radical prostatectomy: early results
  publication-title: Urol Oncol
– volume: 96
  start-page: 806
  year: 2005
  end-page: 10
  article-title: Defining the minimum hospital case‐ load to achieve optimum outcomes in radical cystectomy
  publication-title: BJU Int
– volume: 43
  start-page: 350
  year: 2009
  end-page: 6
  article-title: Nationwide population‐based study on 30‐day mortality after radical prostatectomy in Sweden
  publication-title: Scand J Urol Nephrol
– volume: 55
  start-page: 1037
  year: 2009
  end-page: 63
  article-title: Retropubic, laparoscopic, and robot‐assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies
  publication-title: Eur Urol
– volume: 174
  start-page: 903
  year: 2005
  end-page: 7
  article-title: Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens
  publication-title: J Urol
– volume: 100
  start-page: 1040
  year: 2007
  end-page: 9
  article-title: Patient outcomes and length of hospital stay after radical prostatectomy for prostate cancer: analysis of hospital episodes statistics for England
  publication-title: BJU Int
– volume: 28
  start-page: 243
  year: 2010
  end-page: 50
  article-title: Impact of surgeon and hospital volume on outcomes of radical prostatectomy
  publication-title: Urol Oncol
– volume: 179
  start-page: 2212
  year: 2008
  end-page: 6
  article-title: Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories
  publication-title: J Urol
– volume: 78
  start-page: 911
  year: 1996
  end-page: 8
  article-title: A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome
  publication-title: Br J Urol
– volume: 50
  start-page: 98
  year: 2006
  end-page: 104
  article-title: Intra‐ and peri‐operative outcomes comparing radical retropubic and laparoscopic radical prostatectomy: results from a prospective, randomised, single‐surgeon study
  publication-title: Eur Urol
– volume: 340
  start-page: c1128
  year: 2010
  article-title: The volume‐mortality relation for radical cystectomy in England: retrospective analysis of hospital episode statistics
  publication-title: BMJ
– volume: 184
  start-page: 2291
  year: 2010
  end-page: 6
  article-title: The learning curve for laparoscopic radical prostatectomy: an international multicenter study
  publication-title: J Urol
– volume: 167
  start-page: 1681
  year: 2002
  end-page: 6
  article-title: Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis
  publication-title: J Urol
– volume: 56
  start-page: 651
  year: 2009
  end-page: 7
  article-title: Reducing laparoscopic radical prostatectomy false‐positive margin rates using cyanoacrylate tissue glue
  publication-title: Eur Urol
– volume: 103
  start-page: 1224
  year: 2009
  end-page: 30
  article-title: The first 1000 cases of laparoscopic radical prostatectomy in the UK: evidence of multiple ‘learning curves’
  publication-title: BJU Int
– volume: 349
  start-page: 2117
  year: 2003
  end-page: 27
  article-title: Surgeon volume and operative mortality in the United States
  publication-title: N Engl J Med
– ident: e_1_2_8_2_2
– ident: e_1_2_8_5_2
– ident: e_1_2_8_14_2
  doi: 10.1016/j.eururo.2006.02.051
– ident: e_1_2_8_6_2
  doi: 10.1111/j.1464-410X.2007.07118.x
– ident: e_1_2_8_10_2
  doi: 10.1016/j.eururo.2009.01.036
– ident: e_1_2_8_18_2
  doi: 10.1111/j.1464-410X.2005.05717.x
– ident: e_1_2_8_13_2
  doi: 10.1016/j.urolonc.2005.11.039
– ident: e_1_2_8_19_2
  doi: 10.1136/bmj.c1128
– ident: e_1_2_8_16_2
  doi: 10.1016/j.juro.2008.01.107
– ident: e_1_2_8_23_2
  doi: 10.1016/S0022-5347(05)65177-4
– ident: e_1_2_8_25_2
  doi: 10.1016/j.juro.2006.04.048
– ident: e_1_2_8_24_2
  doi: 10.1016/S0022-5347(05)64670-8
– ident: e_1_2_8_15_2
  doi: 10.1056/NEJMsa035205
– ident: e_1_2_8_21_2
  doi: 10.1016/j.juro.2010.08.003
– ident: e_1_2_8_12_2
  doi: 10.1097/01.ju.0000169475.00949.78
– ident: e_1_2_8_9_2
  doi: 10.1016/j.urolonc.2009.07.014
– ident: e_1_2_8_3_2
– ident: e_1_2_8_17_2
  doi: 10.1016/j.urolonc.2009.03.001
– ident: e_1_2_8_11_2
  doi: 10.1111/j.1464-410X.2005.05245.x
– ident: e_1_2_8_22_2
– ident: e_1_2_8_26_2
  doi: 10.1016/j.eururo.2008.12.001
– ident: e_1_2_8_7_2
  doi: 10.1046/j.1464-410X.1996.00619.x
– ident: e_1_2_8_4_2
– ident: e_1_2_8_20_2
  doi: 10.3109/00365590902916930
– ident: e_1_2_8_8_2
  doi: 10.1111/j.1464-410X.2008.08169.x
SSID ssj0014665
Score 2.201463
Snippet Study Type – Therapy (outcomes) Level of Evidence 2b What’s known on the subject? and What does the study add? A slowly emerging body of urological outcome...
To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes...
Study Type - Therapy (outcomes) Level of Evidence2b What's known on the subject? and What does the study add? A slowly emerging body of urological outcome data...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 346
SubjectTerms Adult
Aged
Aged, 80 and over
Biological and medical sciences
Blood Loss, Surgical - statistics & numerical data
Clinical Competence - standards
Gynecology. Andrology. Obstetrics
Humans
Hypotheses
Length of Stay
Lymph Node Excision - standards
Lymph Node Excision - statistics & numerical data
Lymphatic Metastasis
Male
Male genital diseases
Medical sciences
Middle Aged
Multivariate analysis
Neoplasm Grading
Nephrology. Urinary tract diseases
Organ Size
outcome
Prostate cancer
prostate size
Prostate-Specific Antigen - blood
Prostatectomy - standards
Prostatectomy - statistics & numerical data
Prostatic Neoplasms - pathology
Prostatic Neoplasms - surgery
radical prostatectomy
surgeon volume
Tumors
Tumors of the urinary system
United Kingdom
Urinary tract. Prostate gland
Urology - standards
Urology - statistics & numerical data
Workload - statistics & numerical data
Title UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2011.10334.x
https://www.ncbi.nlm.nih.gov/pubmed/21771246
https://www.proquest.com/docview/1353352980
https://www.proquest.com/docview/916518584
Volume 109
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1464-410X
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0014665
  issn: 1464-4096
  databaseCode: ABDBF
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1464-410X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0014665
  issn: 1464-4096
  databaseCode: DIK
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1464-4096
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1464-410X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014665
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh1IofT_cpmEOvXpZW1p71VtfIaSkhTYLexMjrXxJai9rL6T5L_mvnZG8bh1yCKXgg7E8Y1sezXx6fSPE27xSlSUYndqs0KlCj6mlW9O5LZzUyqF1PA558rU4Wqjj5WzZr3_ivTCRH2IYcOOWEfw1N3C07fVGrlKVTZeRiTObSqkmjCczWYTe1feBSYpuDVklowjB9vGinhsVjSLV_TW2VGlVzHZxExwdo9sQng4firPdh8VVKWeTbWcn7vIa5-P_-fJH4kGPYuF9NLvH4o6vn4i7J_08_VNxtfgCGwxTQLDmfSXIcxXNz1_QbDt6nG8B6xW0vCe7qcFRKIXoJ98Bx9UV0FXkI1KmQFMBIVXoKZjgL6PiosVm58LhR1TZAju6c38B39Y-GnkLn7BD1v5MnB5-Pv14lPaJIFKnqNecrhxi6WTheagBZy5nnEdenMBGWeo8rzhJjUSdT22OnE5ZoiekO0eKy9Zq-Vzs1U3tXwrQ1N-tCq0Kr8OeY7RKzbyvJJbeE7RLRLn758b1JOmcq-PcjDpLynDlG658EyrfXCQiGyTXkSjkFjIHI7MaBDlJATMRJmJ_Z2em9y2t4UwlBJv1fJoIGIrJK_BUD9a-2baGQP-MkNhcJeJFNM8_urOyJFBHustgZLd-W_PheBFOX_2z5Gtxj67ncdX7vtjrNlv_hkBdZw9Cc_0NNPM9Ow
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hIgFSxRtqKGUOXB35sbFjbkCpQtsUCRIpt9XsZn0h2FHsSG3_S_9rZ7yOwVUPFULywbJ3xvZ6dubb1zdCfIhymWuC0b4Ok8yXaNHXVNQf6cTEmTSoDY9DTs6S8Uwez4fzNh0Q74Vx_BDdgBu3jMZfcwPnAembrVz6MgzmjoozDOJYDghQ3qfrAZv44Y-OS4rKNnklnQwB9_6ynls19WLV7gorqrbc5bu4DZD28W0ToI6eiOX209y6lF-DTa0H5vIG6-N_-van4nELZOGTs7xn4p4tnosHk3aq_oW4mp3AGptZIFjx1hLk6Yry9wWUm5qeZyvAYgEVb8suCzAUTcG5yo_AoXUBdBX5cKwpUOZAYBVaFib4y6741my99eLw06msgH3d0p7D95V1dl7BIdbI2l-K6dHX6Zex3-aC8I2kjrO_MIipiRPLow04NBFDPXLkhDfSNIuinPPUxJhFgY6QMyrHaAnsjpBCs9ZZ_ErsFGVh9wRk1OXNk0wmNmu2HaOWcmhtHmNqLaE7T6Tbn65My5PO6TqWqtdfkoorX3Hlq6by1bknwk5y5bhC7iBz0LOrTpDzFDAZoSf2t4amWvdSKU5WQsg5GwWegO42OQae7cHClptKEe4fEhgbSU-8dvb5R3eYpoTrSHfaWNmd31Z9Pp41p2_-WfK9eDieTk7V6bezk7fiEZWJ3CL4fbFTrzf2HWG8Wh80bfcaF4RBXA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQkSokxPsRKGUOXLPaJM7D3IBlVVpaEHSlvVnjrHNhSaJNVir8F_4rM3E2kKqHCiHlECWeSeKMZz6_vhHiVVjIwhCM9k2QKF-iRd9QUT8zSR4pmaPJeRzy9Cw5WsjjZbzs0wHxXhjHDzEMuHHL6Pw1N3Bbr4rLrVz6MpguHRVnMI0iOSFAeVPGKuP1fbMvA5cUle3ySjoZAu7jZT1XahrFqts1NlRthct3cRUgHePbLkDN74r17tPcupRvk21rJvnPS6yP_-nb74k7PZCFN87y7osbtnwg9k_7qfqH4tfiBDbYzQJBzVtLkKcrqu8_oNq29DzbAJYraHhbdlVCTtEUnKt8DRxaV0BXkQ_HmgJVAQRWoWdhgr_sim8tNjsvDl-dygbY163tBXyqrbPzBmbYImt_JM7n78_fHfl9Lgg_l9Rx9lc5YppHieXRBozzkKEeOXLCG2mqwrDgPDURqnBqQuSMyhFaArsZUmg2RkWPxV5ZlfapAEVd3iJRMrGq23aMRsrY2iLC1FpCd55Idz9d5z1POqfrWOtRf0lqrnzNla-7ytcXnggGydpxhVxD5nBkV4Mg5ylgMkJPHOwMTffupdGcrISQs8qmnoDhNjkGnu3B0lbbRhPujwmMZdITT5x9_tEdpCnhOtKddlZ27bfVb48X3emzf5Z8KfY_z-b644ezk-fiFhUJ3Rr4A7HXbrb2BUG81hx2Tfc3ZR9A4A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=UK+radical+prostatectomy+outcomes+and+surgeon+case+volume%3A+based+on+an+analysis+of+the+British+Association+of+Urological+Surgeons+Complex+Operations+Database&rft.jtitle=BJU+international&rft.au=Vesey%2C+Sean+G&rft.au=McCabe%2C+John+E&rft.au=Hounsome%2C+Luke&rft.au=Fowler%2C+Sarah&rft.date=2012-02-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1464-4096&rft.eissn=1464-410X&rft.volume=109&rft.issue=3&rft.spage=346&rft_id=info:doi/10.1111%2Fj.1464-410X.2011.10334.x&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=2975470011
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon